Skip to main content
. 2021 Feb 3;3(4):e253–e261. doi: 10.1016/S2665-9913(21)00012-6

Figure 2.

Figure 2

Risk of mortality (A) and adverse clinical outcome (B) according to baseline C-reactive protein in patients diagnosed with COVID-19 and hyperinflammation

Dots represent individual observations, solid lines represent multivariable model-derived probabilities, and shaded areas represent 95% CIs.